Two recent analyses provide new insight into the clinical efficacy of BCG versus chemotherapy with mitomycin C in intermediate-risk and high-risk bladder cancer. BCG immunotherapy showed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback